Thomas Flaten
Stock Analyst at Lake Street
(4.44)
# 1,149
Out of 4,556 analysts
335
Total ratings
51.2%
Success rate
9.7%
Average return
Main Sectors:
Stocks Rated by Thomas Flaten
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BLFS BioLife Solutions | Downgraded: Hold | $33 → $31 | $30.68 | +1.04% | 26 | Jul 22, 2026 | |
| PSNL Personalis | Downgraded: Hold | $11 → $16 | $13.01 | +24.90% | 29 | Jul 21, 2026 | |
| CNTB Connect Biopharma Holdings | Maintained: Buy | $9 | $2.20 | +309.33% | 3 | Jul 15, 2026 | |
| HROW Harrow | Maintained: Buy | $60 | $42.88 | +39.93% | 19 | Jul 1, 2026 | |
| DMAC DiaMedica Therapeutics | Reiterated: Buy | $14 | $6.91 | +102.60% | 23 | Jun 23, 2026 | |
| RPID Rapid Micro Biosystems | Maintained: Buy | $8 → $7 | $2.04 | +243.14% | 8 | May 22, 2026 | |
| AQST Aquestive Therapeutics | Maintained: Buy | $6 | $3.95 | +52.09% | 36 | May 15, 2026 | |
| PTHS Pelthos Therapeutics | Maintained: Buy | $50 | $27.29 | +83.22% | 6 | May 15, 2026 | |
| IMDX Insight Molecular Diagnostics | Maintained: Buy | $12 | $4.99 | +140.48% | 23 | May 14, 2026 | |
| AYTU Aytu BioPharma | Maintained: Buy | $8 → $7 | $2.20 | +218.91% | 6 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $5 | $0.4289 | +1,065.77% | 14 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 | $7.24 | +79.68% | 15 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $12.88 | +86.34% | 1 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 | $3.04 | +196.05% | 24 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $52 | $24.03 | +116.40% | 24 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $21.89 | +82.73% | 14 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $6.56 | +67.68% | 30 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $9.60 | n/a | 15 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1.5 | $0.0001 | n/a | 8 | Nov 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $96 → $15 | $0.2818 | n/a | 3 | Apr 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.5 | $2.00 | n/a | 4 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60 → $50 | $57.93 | n/a | 4 | Mar 1, 2022 |
BioLife Solutions
Jul 22, 2026
Downgraded: Hold
Price Target: $33 → $31
Current: $30.68
Upside: +1.04%
Personalis
Jul 21, 2026
Downgraded: Hold
Price Target: $11 → $16
Current: $13.01
Upside: +24.90%
Connect Biopharma Holdings
Jul 15, 2026
Maintained: Buy
Price Target: $9
Current: $2.20
Upside: +309.33%
Harrow
Jul 1, 2026
Maintained: Buy
Price Target: $60
Current: $42.88
Upside: +39.93%
DiaMedica Therapeutics
Jun 23, 2026
Reiterated: Buy
Price Target: $14
Current: $6.91
Upside: +102.60%
Rapid Micro Biosystems
May 22, 2026
Maintained: Buy
Price Target: $8 → $7
Current: $2.04
Upside: +243.14%
Aquestive Therapeutics
May 15, 2026
Maintained: Buy
Price Target: $6
Current: $3.95
Upside: +52.09%
Pelthos Therapeutics
May 15, 2026
Maintained: Buy
Price Target: $50
Current: $27.29
Upside: +83.22%
Insight Molecular Diagnostics
May 14, 2026
Maintained: Buy
Price Target: $12
Current: $4.99
Upside: +140.48%
Aytu BioPharma
May 14, 2026
Maintained: Buy
Price Target: $8 → $7
Current: $2.20
Upside: +218.91%
May 14, 2026
Maintained: Buy
Price Target: $9 → $5
Current: $0.4289
Upside: +1,065.77%
May 14, 2026
Maintained: Buy
Price Target: $13
Current: $7.24
Upside: +79.68%
May 8, 2026
Reiterated: Buy
Price Target: $24
Current: $12.88
Upside: +86.34%
May 8, 2026
Maintained: Buy
Price Target: $9
Current: $3.04
Upside: +196.05%
May 7, 2026
Maintained: Buy
Price Target: $52
Current: $24.03
Upside: +116.40%
May 5, 2026
Maintained: Buy
Price Target: $40
Current: $21.89
Upside: +82.73%
Apr 15, 2026
Maintained: Buy
Price Target: $11
Current: $6.56
Upside: +67.68%
May 15, 2025
Maintained: Hold
Price Target: n/a
Current: $9.60
Upside: n/a
Nov 29, 2023
Maintained: Buy
Price Target: $1.5
Current: $0.0001
Upside: n/a
Apr 12, 2023
Maintained: Buy
Price Target: $96 → $15
Current: $0.2818
Upside: n/a
Sep 16, 2022
Maintained: Buy
Price Target: $3.5
Current: $2.00
Upside: n/a
Mar 1, 2022
Maintained: Buy
Price Target: $60 → $50
Current: $57.93
Upside: n/a